accountslow, plodding scientific research and the demands of Wall Street are on stark display in the world of Alzheimer's drug...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ALZHEIMER'S
Given that 26 million people worldwide have Alzheimer's disease and 106 million could be afflicted by 2050, any treatment that alters the course of the disease will become a multi-billion-dollar drug. Major pharmaceutical companies and biotech startups are racing to develop the first drugs to delay or reverse Alzheimer’s. Medical device makers are also developing screening tests to more accurately diagnose Alzheimer’s, and health care providers are trying to find ways to better manage patients.
Alzheimer's is part of Business Exchange, suggested by
Cathy Arnst.
This topic contains
1,254 news
and
1,153 blog
items.
Read updated news, blogs, and resources about Alzheimer's. Find user-submitted articles and reactions on Alzheimer's from
like-minded professionals.
News
Please add new articles to this topic
analyst John Boris says he's downgrading Wyeth (WYE) shares to sell from hold as he removes the experimental...
percent to $81.2 million, chiefly reflecting Elan's efforts to produce treatments and a potential cure for the...
Extract not available.
Top Sources: Alzheimer's
- alzheimersreadingroom.com
- Reuters
- US News
- New York Times
- Mail Online UK
- Los Angeles Times
- Boston Globe
- sciencedaily.com
- rttnews.com
- MarketWatch
Post a Job
Jobs in this Topic
Research Supervisor RN/Registered Nurse - Alzheimer's Disease Center
Rush University Medical Center
|
Chicago, IL
Posted: May 3
RN/Registered Nurse Clinical Coordinator-Rush Alzheimer's Family Care Center
Rush University Medical Center
|
Chicago, IL
Posted: May 7
Neurology- Dementia/Geriatrics neuro117
Scott & White Memorial Hospital - Temple
|
Temple, TX
Posted: Dec 28
Summer Temporary Alzheimer's Disease Center
Rush University Medical Center
|
Chicago, IL
Posted: May 22